AI assistant
Sending…
PegBio Co., Ltd. — Interim / Quarterly Report 2006
Dec 20, 2005
50676_rns_2005-12-20_ad9e2192-9bea-40f4-ab4a-e29cbad57218.htm
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Listed Company Information
| Listed Company Information |
| XIN CORP<01141> - Results Announcement Xin Corporation Limited announced on 20/12/2005: (stock code: 01141 ) Year end date: 31/03/2006 Currency: HKD Auditors' Report: N/A Interim report reviewed by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/04/2005 from 01/04/2004 to 30/09/2005 to 30/09/2004 Note ('000 ) ('000 ) Turnover 2 : 83,888 83,758 Profit/(Loss) from Operations 3 : (93) (6,189) Finance cost : (2,282) (2,387) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (6,281) (9,504) % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.076) (0.169) -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (6,281) (9,504) Interim Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Accounting policies In the current period, the Group has adopted a number of new and revised Hong Kong Financial Reporting Standards and Hong Kong Accounting Standards ("new HKFRS") that are effective for accounting periods commencing on or after 1 January 2005. The adoption of the new HKFRS has resulted in changes in accounting policies and the presentation of various profit and loss account and balance sheet items. Last year's comparative figures are restated to reflect the adoption of new HKFRS during the period. Details of the changes can be found in the Company's interim results announcement and interim report. 2. Turnover Turnover represents the net invoiced value of goods sold, after allowances for returns and trade discounts. For the six months ended 30 September 2005 2004 HK$'000 HK$'000 Continuing operations Supply and procurement business 72,942 65,505 Discontinued operations Toys business 10,946 18,253 ------- -------- 83,888 83,758 ======= ======== 3. Profit/(loss) from operating activities For the six months ended 30 September 2005 Continuing Discontinued operations operations Total HK$'000 HK$'000 HK$'000 Turnover 72,942 10,946 83,888 Cost of sales (64,352) (10,858) (75,210) ----------- ---------- --------- Gross profit 8,590 88 8,678 Other revenue and gains 609 317 926 Selling and distribution costs (153) (276) (429) Administrative expenses (8,433) (835) (9,268) ----------- ----------- ---------- PROFIT/(LOSS) FROM OPERATING ACTIVITIES 613 (706) (93) =========== =========== ========== For the six months ended 30 September 2004 Continuing Discontinued operations operations Total HK$'000 HK$'000 HK$'000 Turnover 65,505 18,253 83,758 Cost of sales (61,649) (18,885) (80,534) ---------- ---------- --------- Gross profit 3,856 (632) 3,224 Other revenue and gains 454 182 636 Selling and distribution costs (162) (502) (664) Administrative expenses (8,436) (949) (9,385) ---------- ----------- ---------- PROFIT/(LOSS) FROM OPERATING ACTIVITIES (4,288) (1,901) (6,189) ========== =========== ========== 4. Loss per share The calculation of basic loss per share is based on the unaudited consolidated loss attributable to equity holders of the parent for the six months ended 30 September 2005 of HK$6,281,000 (Six months ended 30 September 2004: HK$9,504,000 as restated) and 82,704,014 (Six months ended 30 September 2004: weighted average 56,238,730, restated to reflect the open offer during the year ended 31 March 2005 and share consolidation after 31 March 2005) ordinary shares of the Company in issue during the period. Diluted loss per share amounts for the six months ended 30 September 2005 and 2004 have not been disclosed as the convertible notes and bonds and share options outstanding during the period had anti-dilutive effects on the basic loss per share for both periods. |
More from PegBio Co., Ltd.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 19
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Share Issue/Capital Change
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 2
Board/Management Information
2026
Apr 1
Earnings Release
2026
Mar 23